Zacks Research Has Negative Outlook of Surmodics Q2 Earnings
Surmodics, Inc. (NASDAQ:SRDX – Free Report) – Research analysts at Zacks Research decreased their Q2 2026 earnings estimates for shares of Surmodics in a research report issued on Wednesday, May 21st. Zacks Research analyst D. Dey now anticipates that the company will earn $0.02 per share for the quarter, down from their previous forecast of […]
Surmodics, Inc. (NASDAQ:SRDX – Free Report) – Research analysts at Zacks Research decreased their Q2 2026 earnings estimates for shares of Surmodics in a research report issued on Wednesday, May 21st. Zacks Research analyst D. Dey now anticipates that the company will earn $0.02 per share for the quarter, down from their previous forecast of […]
